October 19, 2019

October 18, 2019

Subscribe to Latest Legal News and Analysis

October 17, 2019

Subscribe to Latest Legal News and Analysis

October 16, 2019

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
26
Sep
USDA Releases Additional FAQs on Bioengineered Food Disclosure Standard Keller and Heckman LLP
26
Sep
Opioid Update: 6th Circuit Orders Mandamus Response from Judge Polster, Bellwether Counties Squire Patton Boggs (US) LLP
25
Sep
The FLSA Protects Colorado’s Recreational Cannabis Workers Barnes & Thornburg LLP
25
Sep
FDA Partners With Leafy Greens Stakeholders in Arizona to Enhance Food Safety Keller and Heckman LLP
25
Sep
EUON Study Finds EU Regulatory Framework Ready for Next Generation Nanomaterials Bergeson & Campbell, P.C.
25
Sep
FDA Guidance Clarifies HDE Program Review Epstein Becker & Green, P.C.
24
Sep
DOJ Reaches $21.36 Million Agreement with Compounding Pharmacy, Two of its Executives, and Managing Private Equity Firm to Resolve FCA Allegations Robinson & Cole LLP
24
Sep
StarKist on the Hook for $100M Fine for Tuna Price-Fixing Bilzin Sumberg
24
Sep
Latest Version of TSCA Inventory Includes Unique Identifier Information Bergeson & Campbell, P.C.
24
Sep
Congress Continues to Seek Regulatory Clarity on CBD from FDA Keller and Heckman LLP
24
Sep
NNI Begins Registration for October 8 Webinar on Evaluating Worker and Consumer Exposure to Engineered Nanomaterials Bergeson & Campbell, P.C.
23
Sep
FDA Announces Cooperative Agreement to Implement Produce Safety Rule Keller and Heckman LLP
23
Sep
House Vote on Cannabis Industry-Related SAFE Banking Act Scheduled for September 2019 Dinsmore & Shohl LLP
20
Sep
CBD Food And Drink Products In The EU: The Newest Hot Commodity Or A Regulatory Headache? Keller and Heckman LLP
20
Sep
EPA Includes Unique Identifier Information on Updated TSCA Inventory Bergeson & Campbell, P.C.
20
Sep
Post-BMS, Courts Grapple with the Nexus Between Stream of Commerce Activities and the Plaintiff’s Claim Required for Specific Jurisdiction over Manufacturers in Product Liability Cases Drinker Biddle & Reath LLP
20
Sep
Compounding Pharmacy and Private Equity Firm Owner Agree to $21 Million Settlement to Resolve FCA Allegations Mintz
20
Sep
BRAG Biobased Products Blog: September 20, 2019 Bergeson & Campbell, P.C.
20
Sep
First Valsartan, Now Zantac: Cancer Causing Impurities in Foreign-Made Drugs Stark & Stark
20
Sep
The Overlap of Drug Pricing Proposals McDermott Will & Emery

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Wednesday, October 23, 2019
Wednesday, October 30, 2019
Wednesday, November 6, 2019
Tuesday, November 12, 2019
Wednesday, November 13, 2019
Wednesday, November 13, 2019
Wednesday, November 13, 2019
Wednesday, December 11, 2019